期刊文献+

Losartan activates sirtuin 1 in rat reduced-size orthotopic liver transplantation

Losartan activates sirtuin 1 in rat reduced-size orthotopic liver transplantation
下载PDF
导出
摘要 AIM: To investigate a possible association between losartan and sirtuin 1(SIRT1) in reduced-size orthotopic liver transplantation(ROLT) in rats.METHODS: Livers of male Sprague-Dawley rats(200-250 g) were preserved in University of Wisconsin preservation solution for 1 h at 4 ℃ prior to ROLT.In an additional group,an antagonist of angiotensin Ⅱ type 1 receptor(AT1R),losartan,was orally administered(5 mg/kg) 24 h and 1 h before the surgical procedure to both the donors and the recipients.Transaminase(as an indicator of liver injury),SIRT1 activity,and nicotinamide adenine dinucleotide(NAD+,a co-factor necessary for SIRT1 activity) levels were determined by biochemical methods.Protein expression of SIRT1,acetylated Fox O1(ac-Fox O1),NAMPT(the precursor of NAD+),heat shock proteins(HSP70,HO-1) expression,endoplasmic reticulum stress(GRP78,IRE1 a,p-e IF2) and apoptosis(caspase 12 and caspase 3) parameters were determined by Western blot.Possible alterations in protein expression of mitogen activated protein kinases(MAPK),such as p-p38 and p-ERK,were also evaluated.Furthermore,the SIRT3 protein expression and m RNA levels were examined.RESULTS: The present study demonstrated that losartan administration led to diminished liver injury when compared to ROLT group,as evidenced by the significant decreases in alanine aminotransferase(358.3 ± 133.44 vs 206 ± 33.61,P < 0.05) and aspartate aminotransferase levels(893.57 ± 397.69 vs 500.85 ± 118.07,P < 0.05).The lessened hepatic injury in case of losartan was associated with enhanced SIRT1 protein expression and activity(5.27 ± 0.32 vs 6.08 ± 0.30,P < 0.05).This was concomitant with increased levels of NAD+(0.87 ± 0.22 vs 1.195 ± 0.144,P < 0.05) the co-factor necessary for SIRT1 activity,as well as with decreases in ac-Fox O1 expression.Losartan treatment also provoked significant attenuation of endoplasmic reticulum stress parameters(GRP78,IRE1 a,p-e IF2) which was consistent with reduced levels of both caspase 12 and caspase 3.Furthermore,losartan administration stimulated HSP70 protein expression and attenuated HO-1 expression.However,no changes were observed in protein or m RNA expression of SIRT3.Finally,the protein expression pattern of p-ERK and p-p38 were not altered upon losartan administration.CONCLUSION: The present study reports that losartan induces SIRT1 expression and activity,and that it reduces hepatic injury in a ROLT model. AIM: To investigate a possible association between losartan and sirtuin 1(SIRT1) in reduced-size orthotopic liver transplantation(ROLT) in rats.METHODS: Livers of male Sprague-Dawley rats(200-250 g) were preserved in University of Wisconsin preservation solution for 1 h at 4 ℃ prior to ROLT.In an additional group,an antagonist of angiotensin Ⅱ type 1 receptor(AT1R),losartan,was orally administered(5 mg/kg) 24 h and 1 h before the surgical procedure to both the donors and the recipients.Transaminase(as an indicator of liver injury),SIRT1 activity,and nicotinamide adenine dinucleotide(NAD+,a co-factor necessary for SIRT1 activity) levels were determined by biochemical methods.Protein expression of SIRT1,acetylated Fox O1(ac-Fox O1),NAMPT(the precursor of NAD+),heat shock proteins(HSP70,HO-1) expression,endoplasmic reticulum stress(GRP78,IRE1 a,p-e IF2) and apoptosis(caspase 12 and caspase 3) parameters were determined by Western blot.Possible alterations in protein expression of mitogen activated protein kinases(MAPK),such as p-p38 and p-ERK,were also evaluated.Furthermore,the SIRT3 protein expression and m RNA levels were examined.RESULTS: The present study demonstrated that losartan administration led to diminished liver injury when compared to ROLT group,as evidenced by the significant decreases in alanine aminotransferase(358.3 ± 133.44 vs 206 ± 33.61,P < 0.05) and aspartate aminotransferase levels(893.57 ± 397.69 vs 500.85 ± 118.07,P < 0.05).The lessened hepatic injury in case of losartan was associated with enhanced SIRT1 protein expression and activity(5.27 ± 0.32 vs 6.08 ± 0.30,P < 0.05).This was concomitant with increased levels of NAD+(0.87 ± 0.22 vs 1.195 ± 0.144,P < 0.05) the co-factor necessary for SIRT1 activity,as well as with decreases in ac-Fox O1 expression.Losartan treatment also provoked significant attenuation of endoplasmic reticulum stress parameters(GRP78,IRE1 a,p-e IF2) which was consistent with reduced levels of both caspase 12 and caspase 3.Furthermore,losartan administration stimulated HSP70 protein expression and attenuated HO-1 expression.However,no changes were observed in protein or m RNA expression of SIRT3.Finally,the protein expression pattern of p-ERK and p-p38 were not altered upon losartan administration.CONCLUSION: The present study reports that losartan induces SIRT1 expression and activity,and that it reduces hepatic injury in a ROLT model.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第26期8021-8031,共11页 世界胃肠病学杂志(英文版)
基金 Supported by Grants from Fondo de Investigaciones Sanitarias,No.FIS PI12/00519 fellowship from Agència de Gestiód’Ajuts Universitaris i de Recerca,No.2012FI_B00382 Generalitat de Catalunya,Barcelona,Catalonia,Spain(to Pantazi E)
关键词 LOSARTAN SIRTUIN 1 Endoplasmic reticulumstress Liver ISCHEMIA REPERFUSION injury ANGIOTENSIN Losartan Sirtuin 1 Endoplasmic reticulum stress Liver ischemia reperfusion injury Angiotensin Ⅱ
  • 相关文献

参考文献52

  • 1Quesnelle KM, Bystrom PV, Toledo-Pereyra LH. Molecular responsesto ischemia and reperfusion in the liver. Arch Toxicol 2015;89: 651-657 [PMID: 25566829 DOI: 10.1007/s00204-014-1437-x].
  • 2Du Z, Wei C, Cheng K, Han B, Yan J, Zhang M, Peng C, Liu Y.Mesenchymal stem cell-conditioned medium reduces liver injuryand enhances regeneration in reduced-size rat liver transplantation.J Surg Res 2013; 183: 907-915 [PMID: 23522455 DOI: 10.1016/j.jss.2013.02.009].
  • 3Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome afterpartial liver transplantation: definition, mechanisms of disease andclinical implications. Am J Transplant 2005; 5: 2605-2610 [PMID:16212618 DOI: 10.1111/j.1600-6143.2005.01081.x].
  • 4Ramalho FS, Alfany-Fernandez I, Casillas-Ramirez A, Massip-Salcedo M, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C. Are angiotensin II receptor antagonistsuseful strategies in steatotic and nonsteatotic livers in conditionsof partial hepatectomy under ischemia-reperfusion- J PharmacolExp Ther 2009; 329: 130-140 [PMID: 19116369 DOI: 10.1124/jpet.108.147835].
  • 5Casillas-Ramirez A, Amine-Zaouali M, Massip-Salcedo M,Padrissa-Altés S, Bintanel-Morcillo M, Ramalho F, SerafínA, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C.Inhibition of angiotensin II action protects rat steatotic livers againstischemia-reperfusion injury. Crit Care Med 2008; 36: 1256-1266[PMID: 18379253 DOI: 10.1097/CCM.0b013e31816a023c].
  • 6Paul M, Poyan Mehr A, Kreutz R. Physiology of local reninangiotensinsystems. Physiol Rev 2006; 86: 747-803 [PMID:16816138 DOI: 10.1152/physrev.00036.2005].
  • 7Yang YY, Lee PC, Huang YT, Lee WP, Kuo YJ, Lee KC, HsiehYC, Lee TY, Lin HC. Involvement of the HIF-1α and Wnt/β-catenin pathways in the protective effects of losartan on fattyliver graft with ischaemia/reperfusion injury. Clin Sci (Lond) 2014;126: 163-174 [PMID: 23875703 DOI: 10.1042/CS20130025].
  • 8Koh EJ, Yoon SJ, Lee SM. Losartan protects liver againstischaemia/reperfusion injury through PPAR-γ activation andreceptor for advanced glycation end-products down-regulation.Br J Pharmacol 2013; 169: 1404-1416 [PMID: 23647130 DOI:10.1111/bph.12229].
  • 9Guo L, Richardson KS, Tucker LM, Doll MA, Hein DW, ArteelGE. Role of the renin-angiotensin system in hepatic ischemia reperfusion injury in rats. Hepatology 2004; 40: 583-589 [PMID:15349896 DOI: 10.1002/hep.20369].
  • 10Alfany-Fernandez I, Casillas-Ramirez A, Bintanel-Morcillo M,Brosnihan KB, Ferrario CM, Serafin A, Rimola A, Rodés J, Roselló-Catafau J, Peralta C. Therapeutic targets in liver transplantation:angiotensin II in nonsteatotic grafts and angiotensin-(1-7) insteatotic grafts. Am J Transplant 2009; 9: 439-451 [PMID:19191767 DOI: 10.1111/j.1600-6143.2008.02521.x].

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部